XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.2
COMMON EQUITY (Tables)
 6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Schedule of stock-based compensation awards granted
During the six months ended June 30, 2025, the Compensation Committee of our Board of Directors awarded the following stock-based compensation to our directors, officers, and certain other key employees:
Award TypeNumber of Awards
Stock options (1)
231,024 
Restricted shares (2)
79,170 
Performance units185,945 

(1)Stock options awarded had a weighted-average exercise price of $94.55 and a weighted-average grant date fair value of $18.23 per option.

(2)Restricted shares awarded had a weighted-average grant date fair value of $94.55 per share.
Schedule of Common Stock Outstanding Roll Forward
We had the following changes to our outstanding common stock during the three and six months ended June 30, 2025 and 2024:
Three Months Ended June 30Six Months Ended June 30
2025202420252024
Common stock shares outstanding at beginning of period319,133,501 315,822,587 317,680,855 315,434,531 
Shares issued:
At-the-market offering program2,526,543 — 3,504,367 — 
Stock-based compensation 47,403 20,488 390,114 162,666 
401(k)71,800 122,300 115,100 246,600 
Stock investment plan87,148 114,026 175,959 235,604 
Common stock shares outstanding at end of period321,866,395 316,079,401 321,866,395 316,079,401 
Schedule of Earnings Per Share, Basic and Diluted
The following table shows the computation of our basic and diluted EPS for the three and six months ended June 30, 2025 and 2024:
Three Months Ended June 30Six Months Ended June 30
(in millions)2025202420252024
Numerator:
Net income attributed to common shareholders$245.4 $211.3 $969.6 $833.6 
Denominator:
Weighted average basic shares outstanding320.3315.9319.3315.8
Dilutive effect of stock-based compensation awards0.6 0.3 0.5 0.3 
Dilutive effect of convertible senior notes1.3 — 0.9 — 
Weighted average diluted shares322.2 316.2 320.7 316.1 
Basic EPS$0.77 $0.67 $3.04 $2.64 
Diluted EPS$0.76 $0.67 $3.02 $2.64